FDA Approves MyChoice CDx as Companion Diagnostic for Zejula in Ovarian Cancer
The approval makes MyChoice CDx the sole FDA-approved test in the US to identify HRD-positive patients eligible for niraparib maintenance therapy.
Category: Womens Health
Womens Health
Latest
Womens Health
Latest
Saliva-Based Endometriosis Test Shows 96% Accuracy
The test uses microRNA analysis and AI to diagnose endometriosis in women with chronic pelvic pain when imaging is inconclusive.
Womens Health
Latest
Endometriosis Biomarker Detected by Next-Gen Tech
Researchers have developed a highly sensitive, pregnancy-test-like diagnostic device that uses menstrual blood to detect endometriosis early.
Non-invasive Prenatal Testing Service Launched
Yourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.
Read More
Prognostic Test for Preeclampsia Receives FDA 510(k) Clearance
Roche’s Elecsys sFlt-1/PlGF test received FDA clearance, providing a prognostic way to help ID pregnant women at risk of severe preeclampsia.
Read More
Blood Test May Predict Postpartum Depression Risk Before Symptoms Start
A new study suggests that neuroactive steroid levels in the third trimester may predict postpartum depression risk.
Read More
Mirvie RNA Platform Predicts Severe Fetal Growth Restriction Months Before Birth
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read More
Oral Microbiome Provides Insights to Pregnant Women’s Stress and Mental Health
New research reveals that the saliva of pregnant women shows differences in their oral microbiome based on their levels of life stress.
Read More
Faster Blood Processing Could Improve Gestational Diabetes Diagnosis During Pregnancy
A study found that faster blood processing could double the detection of gestational diabetes, reducing complications for mothers and babies.
Read More
NIH Study Links Abnormal Prenatal DNA Tests to Cancer Detection
NIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read More
Two Genes Identified that Link Rheumatoid Arthritis and Osteoporosis
Researchers identified genes closely linked to both rheumatoid arthritis and osteoporosis, offering diagnostic markers for these diseases.
Read More
Researchers Identify Potential Prenatal Biomarkers of Congenital Heart Diseases
The biomarker could enable prenatal detection of single ventricle heart disease through a maternal blood test for earlier diagnosis.
Read More
Routine Blood Test Identifies Laboring Women at Risk for Preeclampsia
A blood test measuring the fibrinogen-to-albumin ratio can predict the risk of preeclampsia in laboring women, improving maternal outcomes.
Read More
New Stool Test and Therapy Show Promise for Endometriosis Diagnosis and Treatment
Researchers discovered a potential stool test and therapy for endometriosis, based on bacterial metabolites linked to the condition.
Read More
How Genetic Background of Pregnant Women Can Influence NIPT Results
A specific genetic variant found in about 7% of Dutch women reduces the accuracy of NIPT, increasing the likelihood of inconclusive results.
Read More
Ovarian Cancer Test Gets CPT Code and Preliminary Payment Determination from CMS
ClearNote’s ovarian cancer test has been issued a new CPT code by the AMA and preliminary reimbursement rate determinations from CMS.
Read More
Blood Test Predicts 30-Year Cardiovascular Disease Risks for Women
A study found that elevated blood levels of LDL cholesterol, Lp(a), and CRP significantly increase long-term cardiovascular risk.
Read More
Researchers Explore Emerging Solutions for Early Endometriosis Diagnosis
Endometriosis affects over 11% of women and remains challenging to diagnose early, with researchers exploring new diagnostic methods.
Read More